UBS Builds Aixtron Position as Shares Cool Ahead of Critical H1 Report

The Swiss banking giant UBS has increased its stake in Aixtron to 3.84%, crossing a major disclosure threshold in late June. The move signals institutional confidence in the German chip equipment maker even as its stock endures a sharp pullback from recent highs. UBS’s position now comprises 2.96% in direct voting rights and 0.88% through financial instruments, including a convertible bond that alone accounts for 0.61% of voting rights. The buildup from a prior 3.53% stake gives the market a fresh tactical signal from a heavyweight investor.

Aixtron’s shares have been under pressure in recent weeks. The stock closed Wednesday at €51.42, down more than 11% over the past 30 days. The retreat has taken it nearly 18% below its 52-week peak of €62.68, reached on June 18. The 200-day moving average still sits a full 73% lower, a reminder of the extraordinary run that preceded the correction. With an RSI reading of 43.6, the stock is no longer in overbought territory, but annualised volatility remains above 67%, keeping the ride choppy.

The broader picture, however, still shows remarkable gains. Since January, Aixtron has added 162.68% in value. The earlier article noted a 7-day decline of 7.40% and a monthly loss of 15.77% when the stock was at €48.80, underscoring how quickly sentiment has shifted. The 50-day moving average of €52.95 has been broken, with the current price hovering 7.84% below that line.

All eyes now turn to July 30, when Aixtron releases its half-year financial report. The company raised its 2026 revenue guidance just weeks ago, now expecting between €530 million and €590 million, roughly €40 million higher than before, thanks to surprisingly strong optoelectronics demand. But the first quarter was rocky: revenue of €59 million was less than half the prior-year figure of €112.5 million, and special personnel costs pushed the operating margin deep into negative territory. Management still targets an EBIT margin of 17% to 20% for the full year.

Should investors sell immediately? Or is it worth buying Aixtron?

The order book offers a counterweight to the profit pressure. In the first quarter, Aixtron booked €171.4 million in new orders, with several customers placing multi-tool packages that signal long-term commitment. The backlog swelled to €359.1 million as of March 31, up from €257.8 million at the end of 2025. The question hanging over the stock is whether that order momentum can translate into revenue and earnings growth fast enough to justify the valuation.

Analyst views remain polarized. Barclays recently reaffirmed a price target of €39, well below current levels and implying further downside. Jefferies, by contrast, sees more upside even after the rally and lifted its target from €55.30 to €73. The divergence underscores the uncertainty surrounding Aixtron’s ability to convert its technology wins into consistent profitability.

The UBS stake increase adds a layer of institutional endorsement that could help steady nerves ahead of the July 30 report. If the half-year numbers confirm that the order boom is feeding through to the bottom line, the recent correction may prove short-lived. If not, the stock could face another leg down.